The Joint (JYNT)
(Delayed Data from NSDQ)
$15.93 USD
-0.49 (-2.98%)
Updated May 28, 2024 04:00 PM ET
After-Market: $15.96 +0.03 (0.19%) 7:58 PM ET
1-Strong Buy of 5 1
C Value B Growth C Momentum B VGM
Brokerage Reports
0 items in cart
The Joint Corp. [JYNT]
Reports for Purchase
Showing records 21 - 40 ( 149 total )
Company: The Joint Corp.
Industry: Medical - HMOs
Company: The Joint Corp.
Industry: Medical - HMOs
Company: The Joint Corp.
Industry: Medical - HMOs
Company: The Joint Corp.
Industry: Medical - HMOs
Company: The Joint Corp.
Industry: Medical - HMOs
Company: The Joint Corp.
Industry: Medical - HMOs
Company: The Joint Corp.
Industry: Medical - HMOs
Join Our Management Webinar - Thursday, Sep. 15 at 2PM ET
Provider: Roth Capital Partners, Inc.
Analyst: KELLY G
Company: The Joint Corp.
Industry: Medical - HMOs
Company: The Joint Corp.
Industry: Medical - HMOs
System Momentum Continues; Owned Segment Stabilizing; Reit Buy, PT to $36
Provider: Roth Capital Partners, Inc.
Analyst: KELLY G
Company: The Joint Corp.
Industry: Medical - HMOs
Reviewing Our Thesis Following Challenging Period
Provider: Roth Capital Partners, Inc.
Analyst: KELLY G
Company: The Joint Corp.
Industry: Medical - HMOs
Company: The Joint Corp.
Industry: Medical - HMOs
Company: The Joint Corp.
Industry: Medical - HMOs
Brand Momentum Keeps Us At Buy Despite Challenges; PT to $40
Provider: Roth Capital Partners, Inc.
Analyst: KELLY G
Company: The Joint Corp.
Industry: Medical - HMOs
Staying at Buy Despite Greenfield Drag on Profitability; PT to $75
Provider: Roth Capital Partners, Inc.
Analyst: KELLY G
Company: The Joint Corp.
Industry: Medical - HMOs
Company: The Joint Corp.
Industry: Medical - HMOs
Company: The Joint Corp.
Industry: Medical - HMOs
Management Meeting Highlights; Reit Buy, PT to $80
Provider: Roth Capital Partners, Inc.
Analyst: KELLY G